A fixed rule set over this filing's XBRL figures and the number of high-severity risks found in it — no model judgement.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
IDEX Corporation reported Q2 FY2026 revenue of $920.6M (+6.4% YoY) and diluted EPS of $1.93 (+10.9% YoY), driven by strong demand in Health & Science Technologies and net gains from IEEPA tariff refunds.
Revenue
$920.6M
+6.38% YoY
EPS (Diluted)
$1.93
+10.92% YoY
Gross Margin
46.4%
+1.0 pts YoY
Operating Income
$199.9M
+6.39% YoY
Idex (IEX) reported Q2 FY2026 revenue of $920.6M, up 6.4% year over year. The company posted net income of $143.4M, up 9.0% from a year earlier, with diluted EPS of $1.93. Gross margin was 46.4%. Operating income was $199.9M, up 6.4% year over year. IEX's fiscal Q2 FY2026 corresponds to calendar Q2 2026.
IDEX delivered solid Q2 FY2026 results with revenue of $920.6M (+6.4% YoY) and net income of $143.4M (+9.0% YoY), supported by AI data center momentum and tariff refunds.
Last 4 quarters: 4 beats
Adjusted (non-GAAP) EPS of $2.32 versus the $2.13 analyst consensus — a +8.9% beat for Jun 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was $1.93.
Health & Science Technologies (HST) net sales increased 14% YoY to $415.0M (12% organic), fueled by AI-driven demand for data center power, semiconductor markets, and space and defense.
Source: 10-Q Item 2 MD&A, p.29
Following a U.S. Supreme Court ruling invalidating IEEPA tariffs, IDEX collected refunds that reduced Cost of Sales by $22.0M and Net Sales by $14.7M (due to customer rebates), contributing a net $0.08 benefit to diluted EPS.
Source: 10-Q Item 2 MD&A, p.26
Segment net sales were led by HST at $415.0M (+14%), followed by Fluid & Metering Technologies at $317.1M (+2% YoY with flat volume), while Fire & Safety/Diversified Products fell 1% to $189.9M due to lower European rescue and dispensing demand.
Source: 10-Q Item 2 MD&A, p.29-31
In Q2 FY2026, IDEX returned capital through $77.1M in share repurchases ($153.4M YTD) and $53.9M in dividends ($106.7M YTD), with $774.7M remaining under its share repurchase authorization as of June 30, 2026.
Source: 10-Q Item 2 MD&A, p.26, 33
Net sales in the Fire & Safety/Diversified Products segment contracted 1% YoY during Q2 FY2026 due to lower European rescue and dispensing volumes. Continued industrial macroeconomic softness could further dampen order volumes across IDEX's diversified business units.
Source: 10-Q Income Statement (XBRL)
Trade policy shifts and associated customer rebate adjustments reduced Q2 FY2026 net sales by $14.7M. Ongoing implementation of alternative tariffs by regulatory authorities may create margin unpredictability and dynamic pricing pressures.
Source: 10-Q Income Statement (XBRL)
SG&A expenses increased 10.1% YoY to $224.1M, outpacing overall revenue growth of 6.4%, driven by higher employee compensation and professional service costs. Operating working capital also increased by $58.0M YTD to support planned production.
Source: 10-Q Balance Sheet (XBRL)
This analysis does not extract a guidance section. Companies issue revenue and EPS outlook in the 8-K press release and on the earnings call rather than in the 10-Q itself — though the filing's management discussion can contain forward-looking statements, which appear in the highlights above where they were material.
Idex (IEX) is next expected to report on , when the following quarter's results and any updated outlook will be available.
See the IEX earnings preview — expected date, analyst estimates and what to watch →
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $920.6M | $865.4M | +6.38% |
Cost of Revenue | $493.8M | $473.2M | +4.35% |
Gross Profit | $426.8M | $392.2M | +8.82% |
Operating Income | $199.9M | $187.9M | +6.39% |
Net Income | $143.4M | $131.6M | +8.97% |
EPS (Basic) | $1.94 | $1.74 | +11.49% |
EPS (Diluted) | $1.93 | $1.74 | +10.92% |
SG&A Expense | $224.1M | $203.6M | +10.07% |
In Q2 FY2026, IDEX reported revenue of $920.6M (+6.4% YoY) and net income of $143.4M (+9.0% YoY). Results were bolstered by 14% growth in the Health & Science Technologies segment—driven by AI data center and semiconductor demand—along with net benefits from IEEPA tariff refunds.
IDEX's net sales grew 6.4% YoY (5% organic) to $920.6M in Q2 FY2026. Top-line expansion was led by a 14% increase in Health & Science Technologies sales, while Fluid & Metering Technologies grew 2% and Fire & Safety/Diversified Products fell 1%.
Following a U.S. Supreme Court ruling, IDEX collected IEEPA tariff refunds that decreased Cost of Sales by $22.0M and lowered Net Sales by $14.7M due to customer rebates. The net $7.3M gross profit benefit added $0.08 to diluted EPS.
Idex (IEX) is next expected to report earnings on Oct 27, 2026. The date comes from the analyst earnings calendar and can shift until the company confirms it.
Expected release date, analyst estimates & what to watch
IEX delivered strong Q1 FY2026 results with revenue up 8.9% to $886.9M, net income surging 25.7% to $120.0M, and EPS rising 27.8% to $1.61, driven by operating leverage that expanded operating margin by 200 basis points year-over-year.
IEX Group delivered 5.8% revenue growth to $3.46B in FY2025, but net income declined 4.3% to $483.2M as SG&A expenses surged 7.9% and higher costs offset top-line gains.
Other companies in Industrial Machinery & Supplies & Components